Packaging
Latest ORION CORPORATION Patents:
- TEAD inhibitors
- 2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)(5-(phenyl)-pyridin-3-yl)methanone derivatives and similar compounds as CYP11A1 inhibitors for the treatment of prostate cancer
- Pharmaceutical composition of darolutamide
- Method for the preparation of androgen receptor antagonists and intermediates thereof
- Packaging
Description
The file of this patent contains at least one drawing/photograph executed in color. Copies of this patent with color drawing(s)/photograph(s) will be provided by the Office upon request and payment of the necessary fee.
Claims
The ornamental design for a packaging as shown and described.
Referenced Cited
Patent History
Patent number: D1062469
Type: Grant
Filed: Feb 14, 2023
Date of Patent: Feb 18, 2025
Assignee: ORION CORPORATION (Seoul)
Inventors: A Reum Lee (Anyang-si), Hyun A Lee (Seongnam-si)
Primary Examiner: Abraham Bahta
Application Number: 29/884,616
Type: Grant
Filed: Feb 14, 2023
Date of Patent: Feb 18, 2025
Assignee: ORION CORPORATION (Seoul)
Inventors: A Reum Lee (Anyang-si), Hyun A Lee (Seongnam-si)
Primary Examiner: Abraham Bahta
Application Number: 29/884,616
Classifications
Current U.S. Class:
D9/707